Bone Biologics Corp
Follow $BBLG
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BBLG by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredsnapshot unavailable for BBLG. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is BBLG moving today?
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
BBLG overview
Related filings and maps
Congress activity in BBLG
No receipt-qualified filings found.
BBLG contract awards, year to date.
Public federal awards linked to this ticker.
BBLG lobbying filings, year to date.
Registered lobbying filings matched to Bone Biologics Corp.